The Department of Hematology and Blood Disorders is dedicated to providing the most current advanced treatments available to patients with cancers of the blood, bone marrow, or lymph nodes, as well as patients with benign (non-cancerous) blood disorders. Cleveland Clinic Florida’s full-time, dedicated hematologists take a multi-disciplinary approach, collaborating closely with hematopathologists, radiation oncologists and surgeons to diagnosis and treat patients. Our dedicated team of a social worker, clinical psychologist and hematology nurses further enhance and optimize patient care, all resulting in better treatment outcomes and a quality experience for patients in South Florida.
Our physicians treat hematologic malignancies, including non Hodgkin and Hodgkin lymphoma, multiple myeloma, amyloidosis, acute leukemia, chronic leukemia, bone marrow failure disorders (aplastic anemia, paroxysmal nocturnal hemoglobinuria, myelodysplastic syndromes, LGL leukemia, pure red cell aplasia), myeloproliferative disorders (polycythemia vera, essential thrombocytosis, chronic myeloid leukemia, systemic mastocytosis, myelofibrosis), coagulation disorders, sickle cell anemia, clotting disorders and a variety of other benign and malignant disorders.
For more information about our success rates, services and programs, and research and education, please download the outcomes report.
Acute leukemia is managed in a dedicated inpatient unit by a multidisciplinary team in an academic setting. Our department provides the newest treatments, including several national studies sponsored by the National Cancer Institute. Patients benefit from the special expertise of the program’s physicians and from their close collaboration with Cleveland Clinic's Bone Marrow Transplant Program in Ohio.
Our department offers evaluation, treatment and consultative services in the field of benign and malignant hematologic disorders. The benign areas include disorders of:
- Red cells, white cells, platelets
- Hemostasis (bleeding disorders) and thrombosis (clotting disorders)
- Genetic disorders, such as hemoglobinopathies, enzymatic disorders, and the porphyrias
- Diagnostic work up of symptomatic presentations, such as fevers, and the lymphadenopathy
Bone Marrow Failure
Cleveland Clinic Florida is dedicated to the diagnosis and treatment of patients with myelodysplastic syndromes (MDS), aplastic anemia, paroxysmal nocturnal hemoglobinuria, and other bone marrow failure conditions. We collaborate closely with Cleveland Clinic in Ohio - recognized as a leader in pioneering diagnostic techniques and therapies by patient groups and national and international treatment and research organizations. Our physicians were involved in pivotal study that led to the approval of eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria.
Lymphoma, Multiple Myeloma & Chronic Leukemia
The Department of Hematology & Blood Disorders offers a comprehensive, multidisciplinary program for the diagnosis and treatment of Hodgkin, non-Hodgkin lymphoma, chronic leukemia and multiple myeloma; education and support of patients and their families; investigation of lymphoma pathobiology; and development of innovative treatments.
Our department has a unique interest and expertise in Amyloidosis. Patients have access to specialists in cardiology, nephrology and neurology that are very experienced in this condition. We offer our patients access to clinical trials in amyloidosis. Dr. Hoffman is an editor for the amyloid section of NORD (National Organization of Rare Disorders) and is associated with the Amyloidosis Foundation.
Cleveland Clinic Florida's Cancer Institute is dedicated to the best cancer care available for patients. Our program includes clinical trials sponsored by the National Cancer Institute (NCI), Pharmaceutical sponsored clinical trials and trials opened at Cleveland Clinic's main campus in Ohio.
Our integration and collaboration with Cleveland Clinic in Ohio allow us access to their portfolio of clinical trials. We believe that this access provides a unique opportunity to patients in Florida to novel agents. Our pharmaceutical sponsored studies as well as the NCI studies are chosen carefully in order to offer expanded treatment options to our patients.
Cleveland Clinic Florida is part of a community-based cancer research program established by the NCI. The aim of the program is to provide cancer patients with access to NCI-sponsored cancer treatment trials and up-to-date cancer management. Through this comprehensive organized clinical trial mechanism we can bring the latest cancer prevention and treatment research findings to our community.
Cleveland Clinic Florida runs a number of clinical tirals.